Location History:
- Taoyuan Shien, TW (2006)
- Taoyuan Hsien, TW (2001 - 2009)
- Taoyuan, TW (2008 - 2021)
Company Filing History:
Years Active: 2001-2021
Title: Innovations of Inventor Wen-Ching Wu
Introduction
Wen-Ching Wu is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of chemistry and imaging technology, holding a total of eight patents. His work focuses on the development of novel methods for preparing organoboron derivatives and contrast agent precursors.
Latest Patents
One of his latest patents is a method for preparing organoboron derivatives containing oxygen and an aromatic ring, which serves as labeled precursors for dopamine positron emission tomography imaging agents. This innovative method utilizes hydrochloride salt of cocaine as an initiator. The process involves only five steps, significantly reducing the time required and improving the total yield rate. Another recent patent involves a contrast agent precursor that includes a 1,4,7-Tris(carbonylmethyl)-1,4,7,10-tetraazacyclododecane, which forms complexes with radioisotopes or connects to peptides. This precursor enhances binding specificity, labeling accuracy, and detection sensitivity, while also addressing issues related to conventional synthesis.
Career Highlights
Wen-Ching Wu has worked with prominent organizations such as Delta Electronics, Inc. and the Institute of Nuclear Energy Research, Atomic Energy Council, Executive Yuan, R.O.C. His experience in these institutions has contributed to his expertise in the field of nuclear energy and imaging technologies.
Collaborations
Throughout his career, Wen-Ching Wu has collaborated with several professionals, including Jui-Yuan Hsu and Yu Lung Chang. These collaborations have fostered innovation and advancement in his research endeavors.
Conclusion
Wen-Ching Wu's contributions to the field of chemistry and imaging technology are noteworthy. His innovative methods and collaborations have led to significant advancements in the preparation of organoboron derivatives and contrast agents. His work continues to impact the scientific community positively.